Open access · US-GOV via ClinicalTrials.gov Clinical trial

Metformin to Prevent Inactivity-induced Loss of Muscle Health During Aging

Authors not listed

University of Utah · 2019

Dysbiosis Metformin Human Randomized controlled trial

Abstract

Muscle atrophy and insulin resistance are common after bed rest in healthy older adults. Metformin treatment has been shown to improve insulin sensitivity and attenuate muscle loss in insulin resistance adults though the mechanisms are not fully known. Metformin used as a preventive strategy to maintain muscle and metabolic health in bed ridden older adults has not been investigated.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-05-29 MST

Cite this

APA

Anonymous. (2019). Metformin to Prevent Inactivity-induced Loss of Muscle Health During Aging. <em>University of Utah</em>. https://clinicaltrials.gov/study/NCT03107884

Vancouver

Anonymous. Metformin to Prevent Inactivity-induced Loss of Muscle Health During Aging. University of Utah. 2019.

BibTeX

@misc{anon2019Metfor, title = {Metformin to Prevent Inactivity-induced Loss of Muscle Health During Aging}, author = {Anonymous}, journal = {University of Utah}, year = {2019}, }